RESECTABLE NSCLC
Clinical trials for RESECTABLE NSCLC explained in plain language.
Never miss a new study
Get alerted when new RESECTABLE NSCLC trials appear
Sign up with your email to follow new studies for RESECTABLE NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo targets tough lung cancer mutation before surgery
Disease control Recruiting nowThis study tests a new treatment plan for people with a specific type of lung cancer (KRAS G12C mutation) that can be removed with surgery. Before surgery, patients receive a targeted drug (fulzerasib) for 6 weeks, then a break, followed by 3 cycles of immunotherapy (sintilimab) …
Matched conditions: RESECTABLE NSCLC
Phase: PHASE2 • Sponsor: Jianxing He • Aim: Disease control
Last updated May 26, 2026 11:01 UTC
-
New combo before lung surgery shows promise in early trial
Disease control Recruiting nowThis study is for people with a type of lung cancer (NSCLC) that can be removed with surgery. It tests giving a drug called tislelizumab along with radiation therapy before the operation. The goal is to see if this combination can shrink the tumor more effectively. About 20 adult…
Matched conditions: RESECTABLE NSCLC
Phase: PHASE2 • Sponsor: Northern Jiangsu People's Hospital • Aim: Disease control
Last updated May 26, 2026 11:01 UTC